Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012
by Onyx Pharmaceuticals.
Recruitment status was Active, not recruiting
Study NCT00530816 Information provided by Onyx Pharmaceuticals
First Received on September 14, 2007. Last Updated on August 21, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
Sponsors listed in this trial
Onyx Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers